Hilzinger Buys Outlook Stock
Outlook Therapeutics director Kurt J. Hilzinger purchases company stock, showing insider confidence. The buy totals $176,520.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Outlook Therapeutics director Kurt J. Hilzinger purchases company stock, showing insider confidence. The buy totals $176,520.